Nautilus Biotechnology, Inc.

NAUT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$23,875$34,457$33,238$27,646
Short-Term Investments$107,552$113,416$105,572$102,247
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,898$2,852$2,791$2,933
Total Curr. Assets$134,325$150,725$141,601$132,826
Property Plant & Equip (Net)$28,351$29,648$30,886$32,332
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$37,059$31,636$54,023$76,405
Tax Assets$0$0$0$0
Other NC Assets$1,180$1,180$1,180$1,180
Total NC Assets$66,590$62,464$86,089$109,917
Other Assets$0$0$0$0
Total Assets$200,915$213,189$227,690$242,743
Liabilities
Payables$893$974$841$987
Short-Term Debt$4,209$4,225$4,242$4,097
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,880$2,938$3,073$2,548
Total Curr. Liab.$8,982$8,137$8,156$7,632
LT Debt$22,794$23,958$25,099$26,381
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$22,794$23,958$25,099$26,381
Other Liabilities$0$0$0$0
Cap. Leases$22,794$28,183$29,341$30,478
Total Liabilities$31,776$32,095$33,255$34,013
Equity
Pref Stock$0$0$0$0
Common Stock$13$13$13$13
Retained Earnings-$318,239-$304,665-$289,632-$273,019
AOCI$200$77$189$57
Other Equity$487,165$485,669$483,865$481,679
Total Equity$169,139$181,094$194,435$208,730
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$200,915$213,189$227,690$242,743
Net Debt$3,128-$6,274-$3,897$2,832
Nautilus Biotechnology, Inc. (NAUT) Financial Statements & Key Stats | AlphaPilot